ImmunoPrecise Antibodies (IPA) Q3 2025 Earnings Call March 28, 2025 05:13 PM ET Company Participants Jennifer Bath - CEO, President & Non-Independent DirectorJoseph Scheffler - Interim CFODaby Benjaminé Carreras - Financial Advisors Conference Call Participants Ramakanth Swayampakula - Managing Director & Senior Research Analyst Operator Good morning, ladies and gentlemen, and thank you for joining us today for Immunoprecise Antibody's Third Quarter Fiscal Year twenty twenty five Earnings Call. We appreciat ...